Literature DB >> 21392123

Health and doping in elite-level cycling.

V Lentillon-Kaestner1, M S Hagger, S Hardcastle.   

Abstract

The protection of the health of athletes is one of the three criteria taken into account when registering a substance in the World Anti-Doping Agency prohibited list. Nevertheless, in elite-level cycling, banned substance use is widespread. The present research adopted a psychological approach to examine how or whether perceived health risks influence elite-level cyclists' decisions to use banned substances. Sixteen semi-structured interviews were conducted with cyclists hoping to join a professional team (n=6), neo-professional cyclists (n=2), and former professional cyclists (n=8). Although an evolution was observed in the organization of doping and perceptions of doping over the last decade, the perceived health hazards did not influence, most of the time, decisions to use banned substances among the sample of cyclists. There was a systematization of exogenous substance use in the cycling environment and a trivialization of the side effects of the banned substances. Finally, younger cyclists were not concerned about the long-term health consequences of banned substances; they were more focused on the short-term performance-enhancing benefits. There is a need to implement more effective preventive programs to change athletes' attitudes toward doping and its health risks.
© 2011 John Wiley & Sons A/S.

Mesh:

Substances:

Year:  2011        PMID: 21392123     DOI: 10.1111/j.1600-0838.2010.01281.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  13 in total

1.  Challenges to promoting health for amateur athletes through anti-doping policy.

Authors:  April Henning
Journal:  Drugs (Abingdon Engl)       Date:  2016-07-22

Review 2.  Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.

Authors:  Jaime Morente-Sánchez; Mikel Zabala
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

3.  Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.

Authors:  Miran Kondric; Damir Sekulic; Andrea Petroczi; Ljerka Ostojic; Jelena Rodek; Zdenko Ostojic
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-10-11

4.  Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers.

Authors:  Nkaku R Kisaalita; Michael E Robinson
Journal:  J Sports Sci Med       Date:  2014-01-20       Impact factor: 2.988

5.  Cross-cultural adaptation and validation of the spanish version of the performance enhancement attitude scale (petróczi, ).

Authors:  Jaime Morente-Sánchez; Pedro Femia-Marzo; Mikel Zabala
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

6.  Gender- and Sport-Specific Associations Between Religiousness and Doping Behavior in High-Level Team Sports.

Authors:  Milan Zvan; Natasa Zenic; Damir Sekulic; Mladen Cubela; Blaz Lesnik
Journal:  J Relig Health       Date:  2017-08

7.  Inside athletes' minds: preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping.

Authors:  Andrea Petróczi; Jason Mazanov; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-05-20

8.  Attitudes towards doping and related experience in Spanish national cycling teams according to different Olympic disciplines.

Authors:  Jaime Morente-Sánchez; Manuel Mateo-March; Mikel Zabala
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

9.  Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".

Authors:  Wanja Wolff; Ralf Brand
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-06-18

10.  Comparison of the hematological profile of elite road cyclists during the 2010 and 2012 GiroBio ten-day stage races and relationships with final ranking.

Authors:  Giovanni Lombardi; Patrizia Lanteri; Pier Luigi Fiorella; Luigi Simonetto; Franco M Impellizzeri; Marco Bonifazi; Giuseppe Banfi; Massimo Locatelli
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.